Physician

Aftab Husain, M.D.PA

According to 2025 Medicare claims, Aftab Husain, M.D.PA (NPI: 1235131616) practices urology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is AFTAB HUSAIN, M.D, PA (NPI: 1669680377) and primary practice location at 08861-3027.

Husain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 304 traditional Medicare patients, billed 913 HCPCS/CPT codes, and received $94,661 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 4,015 prescription claims across 756 beneficiaries totaling $2,796,703 in drug costs, led by Xtandi (Enzalutamide). DME data shows 13 claims. Open Payments data shows 9 records totaling $1,279. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $230,297 to $94,661. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $392,164 to $2,796,703. For DME billing, this smaller-volume category did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	611	2,615	$230,297
2016	603	2,823	$230,901
2017	523	1,975	$196,550
2018	683	2,309	$235,144
2019	568	2,315	$184,468
2020	462	1,409	$126,699
2021	412	1,087	$115,983
2022	392	1,118	$112,137
2023	348	1,030	$95,746
2024	304	913	$94,661

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	485	2,501	$392,164
2016	510	2,266	$394,491
2017	552	2,810	$389,871
2018	684	2,798	$610,947
2019	701	3,463	$1,261,151
2020	752	4,255	$2,110,021
2021	759	4,097	$2,020,205
2022	694	3,719	$2,185,594
2023	718	3,644	$2,453,569
2024	756	4,015	$2,796,703

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	26	$3,376
2020	N/R	42	$3,975
2021	N/R	47	$2,592
2022	N/R	11	$2,038
2023	N/R	11	$2,232
2024	N/R	13	$2,478

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	50	50	$140
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	177	242	$107
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	136	158	$66
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	37	49	$46
51741	Electronic assessment of bladder emptying	38	41	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	71	2,130	$946,624
Lupron Depot	Leuprolide Acetate	194	10,356	$695,361
Erleada	Apalutamide	28	840	$409,233
Myrbetriq	Mirabegron	290	12,950	$193,983
Orgovyx	Relugolix	53	1,590	$143,399

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	13	$2,478

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$1,279	Teleflex LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aftab Husain, M.D.PA?

Tedicare shows public-source Medicare data for Aftab Husain, M.D.PA (NPI 1235131616), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aftab Husain, M.D.PA have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aftab Husain, M.D.PA?

Aftab Husain, M.D.PA is linked to AFTAB HUSAIN, M.D, PA (billing NPI 1669680377) in the available physician profile data.

Does Aftab Husain, M.D.PA have Open Payments data?

Aftab Husain, M.D.PA has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.